Savortigo-75
Description_Effects
Savortigo-75 contains Cinnarizine 75 mg, a medication primarily used to manage vertigo, motion sickness, and balance disorders caused by inner ear problems. Cinnarizine works by preventing the narrowing of blood vessels in the inner ear, thereby enhancing blood flow and microcirculation. This action helps reduce symptoms such as dizziness, nausea, vomiting, and a spinning sensation (vertigo) often associated with vestibular disorders like Ménière’s disease or labyrinthitis. Savortigo-75 is especially beneficial in treating balance-related issues and helps patients regain stability and coordination. It also has mild antihistamine properties, which can alleviate motion sickness and associated discomfort during travel. By improving inner ear function and reducing abnormal nerve signals, it restores equilibrium and promotes a better quality of life for affected individuals. This medicine should be taken as prescribed by a healthcare provider, preferably after meals to minimize gastric irritation. Drowsiness or dry mouth may occur as side effects, so caution is advised while driving or operating machinery. Savortigo-75 offers a reliable and effective approach for managing inner ear circulation-related dizziness and motion disorders. It is widely used in ENT and neurology practices as a first-line treatment for non-specific vertigo.
